Pfizer CEO runs away from questions on Covid vaccine

Pfizer CEO runs away from questions on Covid vaccine

Albert Bourla, CEO chief executive of US pharmaceutical giant Pfizer, was faced with a series of tough questions about the efficacy of his Covid vaccine on the sidelines of the ongoing World Economic Forum meeting. Albert Bourla did not want to answer any of the up to 29 questions he received in a matter of … Read more

Covid: Scientists’ new warning about AC and closed room

Ground Report | New Delhi: A central government advisory says aerosols can travel up to 10 meters in the air, so skylights should be open indoors to prevent covid infection so that ventilation can take place properly. The risk of infection in open houses is less. This advisory has been issued from the office of the … Read more

Covid-19: 771 new double mutant variants found across country, increased concern


A total of 771 new ‘double mutant variants’ of the corona virus have been found in India. A total of 771 variants have been found in 10,787 samples from 18 states of the country. Of these, 736 are from Britain, 34 from South Africa and one is Brazilian variant. ALSO READ: IIT Delhi Makes 20 Paise … Read more

RSI supports effort of Indian researchers towards developing Covid19 vaccine


Research Scholars of India appreciate the efforts of frontline workers and scientists who have helped develop and bring to market vaccines for the ongoing COVID-19 pandemic. In a statement Nikhil Gupta, National Representative & Coordinator of Research Scholars of India said that some political parties leaders such as Shashi Tharoor, Jairam Ramesh, Milind Deora of … Read more

India’s potential Covid-19 vaccines

Covishield vs Covaxin : which Coronavirus Vaccine is more effective covaxin, corona covaxin, coronavirus vaccine, bharat biotech, corona vaccine,

With the Covid-19 taking a toll on deaths and infections worldwide, the race for developing a Covid-19 vaccine has become more intense. There are currently three candidates globally who have reached the third phase of human trials. The vaccine candidates from AstraZeneca and University of Oxford, Sinopharm and CanSino are the ones among 19 which … Read more